Perspective Therapeutics, Inc. — Director's Dealing 2013

Sep 12, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2013-09-06

Reporting Person: Ragle Brien (Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-06	Stock Options	$0.59	A	5000	Acquired	2023-09-06	Common Stock (5000)	Direct

Footnotes

F1: Right to buy.

F2: 1/3 will vest on 09/06/2014, 1/3 will vest on 09/06/2015, and 1/3 will vest on 09/06/2016.